Elicera Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	34.92	26.4	29.38	43.82	52.39	11.56
Cash & Short-Term Investments	34.92	26.4	29.38	43.82	52.39	11.56
Cash Growth	14.01%	-10.15%	-32.95%	-16.36%	353.04%	34087.00%
Other Receivables	2.37	0.88	0.34	0.33	0.2	0.45
Receivables	2.37	0.88	0.34	0.33	0.2	0.45
Prepaid Expenses	-	0.28	0.45	1.65	1.62	0.05
Other Current Assets	-	-	-	-0	-0.01	-
Total Current Assets	37.3	27.57	30.17	45.8	54.21	12.06
Long-Term Investments	-	0	0	0.48	0.48	0.48
Other Intangible Assets	-	-	0.01	0.02	0.04	0.05
Other Long-Term Assets	-	-	-	-0	0.01	-
Total Assets	37.3	27.57	30.18	46.31	54.74	12.59
Accounts Payable	2.04	2.04	0.88	0.73	2.05	1.95
Accrued Expenses	4.62	4.4	12.5	12.53	0.31	0.29
Current Income Taxes Payable	-	-	-	0.01	0	0
Other Current Liabilities	0.31	0.35	0.4	0.24	0.14	0.11
Total Current Liabilities	6.97	6.8	13.78	13.51	2.5	2.35
Total Liabilities	6.97	6.8	13.78	13.51	2.5	2.35
Common Stock	2.04	1.47	0.83	0.83	0.83	0.51
Additional Paid-In Capital	108.89	86.62	66.79	66.79	66.79	11.99
Retained Earnings	-80.6	-67.33	-51.22	-34.82	-15.38	-2.26
Comprehensive Income & Other	-	-	-	-0	-0	-
Shareholders' Equity	30.33	20.77	16.4	32.8	52.24	10.24
Total Liabilities & Equity	37.3	27.57	30.18	46.31	54.74	12.59
Net Cash (Debt)	34.92	26.4	29.38	43.82	52.39	11.56
Net Cash Growth	14.01%	-10.15%	-32.95%	-16.36%	353.04%	34087.00%
Net Cash Per Share	0.83	0.84	1.49	2.21	3.27	0.96
Filing Date Shares Outstanding	48.54	35.09	19.78	19.78	19.78	12.03
Total Common Shares Outstanding	48.54	35.09	19.78	19.78	19.78	12.03
Working Capital	30.33	20.77	16.39	32.29	51.71	9.71
Book Value Per Share	0.62	0.59	0.83	1.66	2.64	0.85
Tangible Book Value	30.33	20.77	16.39	32.78	52.2	10.19
Tangible Book Value Per Share	0.62	0.59	0.83	1.66	2.64	0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.